Web Analytics

Start up Profile

Ochre Bio

Ochre Bio United Kingdom - Oxford
START UP

1 Disclosed Funding Rounds $30,000,000
0 Participating Investments




Ochre Bio develops RNA therapies for chronic liver diseases, a leading cause of death globally. Privately held, Ochre Bio is situated within the heart of Oxford’s biotech innovation hub.

Capital Raised

Date Round Raised Participating Investors
October, 11 ,2022 Series A $30,000,000